Abstract:An exaggerated inflammatory response is the hallmark of a plethora of disorders. ATP is a central signaling molecule that orchestrates the initiation and resolution of the inflammatory response by enhancing activation of the inflammasome, leukocyte recruitment and activation of T cells. ATP can be released from cells through pannexin (Panx) channels, a family of glycoproteins consisting of three members, Panx1, Panx2, and Panx3. Panx1 is ubiquitously expressed and forms heptameric channels in the plasma membrane mediating paracrine and autocrine signaling. Besides their involvement in the inflammatory response, Panx1 channels have been shown to contribute to different modes of cell death (i.e., pyroptosis, necrosis and apoptosis). Both genetic ablation and pharmacological inhibition of Panx1 channels decrease inflammation in vivo and contribute to a better outcome in several animal models of inflammatory disease involving various organs, including the brain, lung, kidney and heart. Up to date, several molecules have been identified to inhibit Panx1 channels, for instance probenecid (Pbn), mefloquine (Mfq), flufenamic acid (FFA), carbenoxolone (Cbx) or mimetic peptides like 10Panx1. Unfortunately, the vast majority of these compounds lack specificity and/or serum stability, which limits their application. The recent availability of detailed structural information on the Panx1 channel from cryo-electron microscopy studies may open up innovative approaches to acquire new classes of synthetic Panx1 channel blockers with high target specificity. Selective inhibition of Panx1 channels may not only limit acute inflammatory responses but may also prove useful in chronic inflammatory diseases, thereby improving human health. Here, we reviewed the current knowledge on the role of Panx1 in the initiation and resolution of the inflammatory response, we summarized the effects of Panx1 inhibition in inflammatory pathologies and recapitulate current Panx1 channel pharmacology with an outlook towards future approaches.

Pannexins in the musculoskeletal system: new targets for development and disease progression

[The Properties and Research Methods of Pannexins].

The research progress in the functions of pannexin

Pannexin1 channels-a potential therapeutic target in inflammation

Pannexin-1 Channels and Their Emerging Functions in Cardiovascular Diseases.

Pannexin 1 dysregulation in Duchenne muscular dystrophy and its exacerbation of dystrophic features in mdx mice

Advances in the expression and function of pannexins in cochlea

Mechanisms of Pannexin 1 (PANX1) Channel Mechanosensitivity and Its Pathological Roles

Pannexin 1 inhibits rhabdomyosarcoma progression through a mechanism independent of its canonical channel function

Pannexin 1, a Large-Pore Membrane Channel, Contributes to Hypotonicity-Induced ATP Release in Schwann Cells.

Human Pannexin 1 channel: Insight in structure–function mechanism and its potential physiological roles

Recent advances in the structure and activation mechanisms of metabolite-releasing Pannexin 1 channels

Pathophysiological role of connexin and pannexin hemichannels in neuromuscular disorders

Pannexin Hemichannels: A Novel Promising Therapy Target for Oxidative Stress Related Diseases

Expression and function of pannexins in the inner ear and hearing

Dual role for pannexin 1 at synapses: regulating functional and morphological plasticity

Targeting Pannexin-1 Channels: Addressing the 'Gap' in Chronic Pain

Connexin43 and the Intercellular Signaling Network Regulating Skeletal Remodeling

Functional Roles of Connexins and Gap Junctions in Osteo-Chondral Cellular Components

Connexin 43 Hemichannels and Prostaglandin E2 Release in Anabolic Function of the Skeletal Tissue to Mechanical Stimulation

Osterix Facilitates Osteocytic Communication by Targeting Connexin43